Shardul Amarchand Mangaldas Advised Medi Assist Healthcare Services Limited On INR 198 Crores Fundraise

SAM advised Medi Assist on ~INR 198 Cr fundraise via preferential issue to MIT and 238 Plan Associates LLC.

Update: 2025-12-18 07:30 GMT

Shardul Amarchand Mangaldas advised Medi Assist Healthcare Services Limited on INR 198 Crores Fundraise

The leading law firm in India, Shardul Amarchand Mangaldas & Co. (SAM), advised Medi Assist Healthcare Services Limited (“Medi Assist”) on its ~INR 198 crores fundraise through a preferential issue of equity shares to Massachusetts Institute of Technology (MIT) and 238 Plan Associates LLC (collectively, the “Investors”).

The transaction involved the issuance and allotment of fully paid-up equity shares of Medi Assist on a preferential basis to the Investors, who are qualified institutional buyers and SEBI-registered foreign portfolio investors. Following the preferential issue, MIT and 238 Plan Associates LLC hold 3.86% and 1.08%, respectively, of the total share capital of Medi Assist. IIFL Capital Services Limited acted as the financial advisor to the transaction.

The SAM team was led by Prashant Gupta (National Practice Head – Capital Markets) and Devesh Pandey (Partner), with support from Jasmine Khan (Senior Associate), Anushka Ganguli (Associate), and Sourav Paul (Associate).

Click to know more about Shardul Amarchand Mangaldas

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.


Tags:    

Similar News